New York Times |
Severe Eczema Drug Is Approved by FDA; Price Tag Is $37000 a Year
New York Times Debbie Byrnes suffered from severe eczema, but her skin is almost completely clear after using Dupixent for two years. Credit Ilana Panich-Linsman for The New York Times. Advertisement. The Food and Drug Administration on Tuesday approved a drug to ... Regeneron's New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval FDA Approves First Biologic for Moderate to Severe Atopic Dermatitis |
from Health - Google News http://ift.tt/2oeebTz
EmoticonEmoticon